Online ISSN: 2515-8260

Potential of Probiotics for the Treatment of Parkinson’s Disease: A Systematic Review of Clinical studies

Main Article Content

Neha Heer1 , Divyani Verma1 , Satinder Kaur1,2, Rajan Kumar1 , Rakesh Kumar1 , Sonali Bajaj1 , Nisha Sharma1 , Vaishali Koul1 , Neha Morya, Shobit Bansal1 , Nishith Kesarwani1 , Ahmad Farid Habibyar3 , Manish Vyas1 , Jaspreet Kaur1 , Neha Sharma1 , Navneet Khurana*,1

Abstract

ABSTRACT: Millions of people in the world are suffering from neurological disorders such as Parkinson's, strokes, Alzheimer's, anxiety, Parkinson's and so on. Presently around 1 million people suffer from this disease in the united state. It influences around 1- 2% adults with the age of 65 and 4% adults with the age of 80. Parkinson's disease is one of the most common neurodegenerative disorders that is marked by the damage of dopaminergic neurons and the accumulation of alpha-synuclein. It shows the motor and nonmotor symptoms like tremor, rigidity, and bradykinesia, hyposmia, pain, depression, tiredness, orthostatic hypotension and so on. probiotics are living microorganisms that prevent neurological disorders by altering the gut microbiota in the small intestine. Probiotics used in the treatments of Parkinson's disease which balances the gut microbiomes. Clinical and preclinical data shows the beneficial role of probiotics in the treatment of Parkinson’s disease.

Article Details